Laquinimod
Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. It is currently being investigated for its potential use in treating multiple sclerosis and Huntington's disease.
Mechanism of Action[edit | edit source]
Laquinimod is believed to work by modulating the immune system, reducing inflammation and potentially even promoting neuroprotection. However, the exact mechanism of action is not fully understood.
Clinical Trials[edit | edit source]
Laquinimod has undergone several clinical trials to assess its safety and efficacy in treating multiple sclerosis and Huntington's disease.
Multiple Sclerosis[edit | edit source]
In clinical trials for multiple sclerosis, laquinimod has shown a reduction in the rate of relapse and a slowing of disease progression. However, it has not yet been approved for use in this condition.
Huntington's Disease[edit | edit source]
Clinical trials for Huntington's disease are ongoing. Preliminary results suggest that laquinimod may slow the progression of the disease, but further research is needed.
Side Effects[edit | edit source]
Common side effects of laquinimod include back pain, cough, and diarrhea. More serious side effects may include liver damage and severe allergic reactions.
See Also[edit | edit source]
| Laquinimod Resources | ||
|---|---|---|
|
| |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
